Integrated Investment Consultants’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-1,723
Closed -$173K 295
2018
Q1
$173K Buy
+1,723
New +$176K 0.07% 213
2017
Q3
$161K Sell
1,723
-76
-4% -$8.07K 0.07% 196
2017
Q2
$200K Sell
1,799
-30
-2% -$3.17K 0.09% 150
2017
Q1
$180K Hold
1,829
0.08% 166
2016
Q4
$168K Sell
1,829
-40
-2% -$3.45K 0.08% 168
2016
Q3
$156K Hold
1,869
0.08% 173
2016
Q2
$152K Buy
1,869
+176
+10% +$13.4K 0.09% 177
2016
Q1
$122K Buy
+1,693
New +$114K 0.07% 190

Other funds holding DGX

Integrated Investment Consultants's DGX Position: Q2 2018 in Review

Integrated Investment Consultants sold out of Quest Diagnostics (DGX) in Q2 2018, closing a stake of 1,723 shares — an estimated $173K sold.

Integrated Investment Consultants first reported a position in DGX in Q1 2016 and held it in 8 quarters. The position peaked at $200K in Q2 2017. 662 funds tracked by Wall St. Rank hold DGX as of Q2 2018.

  • Integrated Investment Consultants reported no remaining Quest Diagnostics position as of Q2 2018 after selling out during the quarter.
  • Integrated Investment Consultants sold 1,723 Quest Diagnostics shares in Q2 2018, an estimated $173K.
  • Integrated Investment Consultants first reported a position in Quest Diagnostics in Q1 2016 and held it in 8 quarters.
  • Integrated Investment Consultants's Quest Diagnostics position peaked at $200K in Q2 2017.
  • 662 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2018.

Based on Integrated Investment Consultants's 13F filing for Q2 2018, filed 1 Aug 2018.